Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness

Brain Research

Volumn 1190, Issue 1, 2008, Pages 94-104

  Sanford, L D ^a   Yang, L ^a   Wellman, L L ^a   Dong, E ^a   Tang, X ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Astressin; Corticotropin releasing hormone; Mouse strains; Rapid eye movement sleep; Sleep

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE ACTION; MALE; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; REM SLEEP; STRAIN DIFFERENCE; STRESS; TELEMETRY; WAKEFULNESS;

ANIMALS; AROUSAL; CORTICOTROPIN-RELEASING HORMONE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROINJECTIONS; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; SLEEP STAGES; SPECIES SPECIFICITY; WAKEFULNESS;

MUS;

EID: 37549059551     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.11.007     Document Type: Article

References (83)

1. Anisman H., Prakash P., et al. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav. Brain Res. 181 2 (2007) 180-190
2. Bakshi V.P., and Kalin N.H. Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions. Biol. Psychiatry 48 12 (2000) 1175-1198
3. Balcombe J.P., Barnard N.D., et al. Laboratory routines cause animal stress. Contemp. Top Lab. Anim. Sci. 43 6 (2004) 42-51
4. Belzung C., and Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125 1-2 (2001) 141-149
5. Blank T., Nijholt I., et al. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J. Neurosci. 23 2 (2003) 700-707
6. Brauns O., Liepold T., et al. Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments. Neuropharmacology 41 4 (2001) 507-516
7. Calvo J.M., Badillo S., et al. The role of the temporal lobe amygdala in ponto-geniculo-occipital activity and sleep organization in cats. Brain Res. 403 1 (1987) 22-30
8. Calvo J., Simón-Arceo K., et al. Prolonged enhancement of REM sleep produced by carbachol microinjection into the amygdala. NeuroReport 7 (1996) 577-580
9. Chang F.C., and Opp M.R. Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. Am. J. Physiol. 275 3 Pt 2 (1998) R793-R802
10. Chang F.C., and Opp M.R. Pituitary CRH receptor blockade reduces waking in the rat. Physiol. Behav. 67 5 (1999) 691-696
11. Chang F.C., and Opp M.R. Corticotropin-releasing hormone (CRH) as a regulator of waking. Neurosci. Biobehav. Rev. 25 5 (2001) 445-453
12. Chang F.C., and Opp M.R. Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat. Am. J. Physiol., Regul. Integr. Comp. Physiol. 283 2 (2002) R400-R407
13. Chrousos G.P. Stressors, stress, and neuroendocrine integration of the adaptive response. Ann. N. Y. Acad. Sci. 851 (1998) 311-335
14. Crabbe J.C. Genetic differences in locomotor activation in mice. Pharmacol. Biochem. Behav. 25 1 (1986) 289-292
15. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835 1 (1999) 18-26
16. Crawley J.N., Belknap J.K., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132 2 (1997) 107-124
17. Dautzenberg F.M., and Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23 2 (2002) 71-77
18. Davis M. Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect. Pharmacol. Ther. 47 (1990) 147-165
19. Davis M., and Whalen P.J. The amygdala: vigilance and emotion. Mol. Psychiatry 6 1 (2001) 13-34
20. De Boer S.F., Katz J.L., et al. Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock. J. Pharmacol. Exp. Ther. 262 1 (1992) 335-342
21. DeRuisseau L.R., Parsons A.D., et al. Adaptive thermogenesis is intact in B6 and A/J mice studied at thermoneutrality. Metabolism 53 11 (2004) 1417-1423
22. Deussing J.M., and Wurst W. Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour. C. R. Biol. 328 2 (2005) 199-212
23. Ehlers C.L., Reed T.K., et al. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42 6 (1986) 467-474
24. Feldman R., Meyer J., et al. Principles of Neuropsychopharmacology (1997), Sinauer Associates, Inc., Sunderland, Massachusetts
25. Gonzalez M.M., and Valatx J.L. Effect of intracerebroventricular administration of alpha-helical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus. J. Sleep Res. 6 3 (1997) 164-170
26. Gonzalez M.M., and Valatx J.L. Involvement of stress in the sleep rebound mechanism induced by sleep deprivation in the rat: use of alpha-helical CRH (9-41). Behav. Pharmacol. 9 8 (1998) 655-662
27. Goodrick C.L. Life-span and the inheritance of longevity of inbred mice. J. Gerontol. 30 3 (1975) 257-263
28. Griebel G., Belzung C., et al. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 148 2 (2000) 164-170
29. Gulyas J., Rivier C., et al. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl. Acad. Sci. U. S. A. 92 23 (1995) 10575-10579
30. Heinrichs S.C., Menzaghi F., et al. The role of CRF in behavioral aspects of stress. Ann. N.Y. Acad. Sci. 771 (1995) 92-104
31. Henderson N.D. Genetic analysis of an avoidance-avoidance response in Mus domesticus. Behav. Genet. 19 3 (1989) 387-407
32. Hode Y., Ratomponirina C., et al. Hypoexpression of benzodiazepine receptors in the amygdala of neophobic BALB/c mice compared to C57BL/6 mice. Pharmacol. Biochem. Behav. 65 1 (2000) 35-38
33. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 46 9 (1999) 1167-1180
34. Koob G., and Bloom F. Corticotropin-releasing factor and behavior. Fed. Proc. 44 (1985) 259-263
35. Koob G.F., and Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848 1-2 (1999) 141-152
36. Lai Y.Y., and Siegel J.M. Corticotropin-releasing factor mediated muscle atonia in pons and medulla. Brain Res. 575 1 (1992) 63-68
37. Lewis K., Li C., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U. S. A. 98 13 (2001) 7570-7575
38. Liu X., Yang L., et al. The effect of restraint stress on sleep in mice: strain comparison. Sleep 27 (2004) A401
39. Liu X., Tang X., et al. Fear-conditioned suppression of REM sleep: relationship to Fos expression patterns in limbic and brainstem regions in BALB/cJ mice. Brain Res. 991 (2003) 1-17
40. Lovenberg T.W., Liaw C.W., et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U. S. A. 92 3 (1995) 836-840
41. Marrosu F., Gessa G.L., et al. Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res. 515 1-2 (1990) 315-318
42. Meerlo P., Easton A., et al. Restraint increases prolactin and REM sleep in C57BL/6J mice but not in BALB/cJ mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 281 3 (2001) R846-R854
43. Niehoff D., and Kuhar M. Benzodiazepine receptors: localization in rat amygdala. J. Neurosci. 3 (1983) 2091-2097
44. Onoe H., Tsukada H., et al. A subclass of GABAA/benzodiazepine receptor exclusively localized in the limbic system. NeuroReport 8 (1996) 117-122
45. Opp M.R. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv. Neuroimmunol. 5 2 (1995) 127-143
46. Opp M.R. Rat strain differences suggest a role for corticotropin-releasing hormone in modulating sleep. Physiol. Behav. 63 1 (1997) 67-74
47. Opp M., Obal Jr. F., et al. Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am. J. Physiol. 257 3 Pt 2 (1989) R528-R535
48. Overton J.M., and Williams T.D. Behavioral and physiologic responses to caloric restriction in mice. Physiol. Behav. 81 5 (2004) 749-754
49. Pawlyk A.C., Sanford L.D., et al. Corticotropin-releasing factor microinjection into the central nucleus of the amygdala alters REM sleep. Pharmacol. Rep. 58 1 (2006) 125-130
50. Poole S., and Stephenson J.D. Body temperature regulation and thermoneutrality in rats. Q. J. Exp. Physiol. Cogn. Med. Sci. 62 2 (1977) 143-149
51. Reyes T.M., Lewis K., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U. S. A. 98 5 (2001) 2843-2848
52. Roussel B., Turrillot P., et al. Effect of ambient temperature on the sleep-waking cycle in two strains of mice. Brain Res. 294 1 (1984) 67-73
53. Sajdyk T.J., Schober D.A., et al. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav. Brain Res. 100 1-2 (1999) 207-215
54. Sanders S., and Shekhar A. Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biol. Psychiatry 37 (1995) 473-476
55. Sanford L.D., Silvestri A.J., et al. Influence of fear conditioning on elicited ponto-geniculo-occipital waves and rapid eye movement sleep. Arch. Ital. Biol. 139 3 (2001) 169-183
56. Sanford L.D., Tidikis D.E., et al. Carbachol microinjections into the amygdala of rats suppress REM sleep. Soc. Neurosci. Abstracts 23 (1997) 2379
57. Sanford L.D., Fang J., et al. Sleep after differing amounts of conditioned fear training in BALB/cJ mice. Behav. Brain Res. 147 1-2 (2003) 193-202
58. Sanford L.D., Tang X., et al. GABAergic regulation of REM sleep in reticularis pontis oralis and caudalis in rats. J. Neurophysiol. 90 2 (2003) 938-945
59. Sanford L.D., Tang X., et al. Influence of shock training and explicit fear-conditioned cues on sleep architecture in mice: strain comparison. Behav. Genet. 33 1 (2003) 43-58
60. Sanford L.D., Yang L., et al. Influence of contextual fear on sleep in mice: a strain comparison. Sleep 26 5 (2003) 527-540
61. Sanford L.D., Yang L., et al. Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity. Brain Res. 1084 1 (2006) 80-88
62. Sanford L.D., Yang L., et al. Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity. Brain Res. 1084 (2006) 80-88
63. Shibata S., Yamashita K., et al. Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test. Psychopharmacolgy 98 (1989) 38-44
64. Smith G.W., Aubry J., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
65. Spina M.G., Basso A.M., et al. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology 22 3 (2000) 230-239
66. Sternberg E.M., Young III W.S., et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. U. S. A. 86 12 (1989) 4771-4775
67. Tang X., and Sanford L.D. Telemetric recording of sleep and home cage activity in mice. Sleep 25 6 (2002) 691-699
68. Tang X., Orchard S.M., et al. Home cage activity and behavioral performance in inbred and hybrid mice. Behav. Brain Res. 136 (2002) 555-569
69. Tang X., Xiao J., et al. Strain differences in the influence of open field exposure on sleep in mice. Behav. Brain Res. 154 (2004) 137-147
70. Tang X., Xiao J., et al. Differential effects of two types of environmental novelty on activity and sleep in BALB/cJ and C57BL/J mice. Physiol. Behav. 85 (2005) 419-429
71. Tang X.L., Yang L., et al. Influence of tetrodotoxin inactivation of the central nucleus of the amygdala on sleep and arousal. Sleep 28 8 (2005) 923-930
72. Tang X., Yang L., et al. Interactions between brief restraint, novelty, and footshock stress on subsequent sleep and EEG power in rats. Brain Res. 1142 (2007) 110-118
73. Timpl P., Spanagel R., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat. Genet. 19 (1998) 162-166
74. Touret M., Valatx J.L., et al. The locus coeruleus: a quantitative and genetic study in mice. Brain Res. 250 2 (1982) 353-357
75. Valdez G.R., Zorrilla E.P., et al. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res. 980 2 (2003) 206-212
76. Valentino R., and Foote S. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J. Neurosci. 8 (1998) 1016-1025
77. Van Bockstaele E.J., Colago E.E., et al. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J. Neuroendocrinol. 10 10 (1998) 743-757
78. Van Pett K., Viau V., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 2 (2000) 191-212
79. Walker H.C., and Romsos D.R. Glucocorticoids in the CNS regulate BAT metabolism and plasma insulin in ob/ob mice. Am. J. Physiol. 262 1 Pt 1 (1992) E110-E117
80. Williams T.D., Chambers J.B., et al. Diet-induced obesity and cardiovascular regulation in C57BL/6J mice. Clin. Exp. Pharmacol. Physiol. 30 10 (2003) 769-778
81. Wurbel H., Chapman R., et al. Effect of feed and environmental enrichment on development of stereotypic wire-gnawing in laboratory mice. Appl. Anim. Behav. Sci. 60 (1998) 69-81
82. Yadin E., Thomas E., et al. Anxiolytic effects of benzodiazepines in amygdala-lesioned rats. Psychopharmacology 103 (1991) 473-479
83. Zezula J., Cortes R., et al. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscientist 25 (1988) 771-795